About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

WHO to Start Clinical Trial on River Blindness Drug

by VR Sreeraman on July 2, 2009 at 3:40 PM
Font : A-A+

 WHO to Start Clinical Trial on River Blindness Drug

The World Health Organisation said Wednesday it was launching a clinical trial for a drug that could halve the treatment period for river blindness, a disease that threatens 100 million people mostly in Africa.

The phase three trial of the drug moxidectin, in collaboration with Wyeth Pharmaceuticals, would involve 1,500 people in Ghana, Liberia and the Democratic Republic of Congo, said the WHO.

Advertisement

Also called onchocerciasis, river blindness is caused by a parasitic worm whose larvae are transmitted by the bite of the black fly, which breeds by fast-flowing streams.

The larvae migrate under the skin, where they mature into adult worms that produce more eggs.

The eggs then mature into a threadlike state called microfilariae, before developing into larvae.
Advertisement

The microfilariae are especially dangerous as they migrate to the surface of the cornea, causing eye infection and, eventually, blindness.

The clinical trial would examine moxidectin's potential to kill or sterilise adult worms.

River blindness is now being controlled by Merck's ivermectin.

However, the drug kills only the larvae but not the adult worms. As a result, treatment for the disease can last for up to 14 years.

In comparison, if moxidectin proves to be able to neutralise adult worms, it can shorten the treatment period to six years, according to the WHO.

If the trial proves to be positive, the WHO said it would help Wyeth to seek approval for usage in the countries where the disease is endemic.

Source: AFP
LIN
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Lung Transplantation
Baldness can be Cured and Prevented: let us see How!
Drinking Beer or Wine Every Day Could Cause Age-related Diseases
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Signature Drug Toxicity Blindness Facts Placebo Effects: Rare Insights Best Disease Usher Syndrome Onchocerciasis / River Blindness 

Most Popular on Medindia

Accident and Trauma Care Blood Donation - Recipients Loram (2 mg) (Lorazepam) Drug Side Effects Calculator A-Z Drug Brands in India Drug Interaction Checker Sanatogen Indian Medical Journals Find a Doctor Vent Forte (Theophylline)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use